<DOC>
	<DOCNO>NCT02484040</DOCNO>
	<brief_summary>The investigator compare two-week course chemoradiation ( 33 Gy 10 fraction oral capecitabine ) conventional chemoradiation ( 50.4 Gy 28 fraction 5-FU leucovorin ) randomize trial .</brief_summary>
	<brief_title>Two-week Course Versus Conventionally Fractionated Chemoradiotherapy Rectal Cancer</brief_title>
	<detailed_description>1.1 experimental arm Two-week course concurrent chemoradiotherapy - Radiotherapy , 33 Gy/10 fraction 2 week ↓↓↓↓↓ ↓↓↓↓↓ Radical surgery 6 week completion chemoradiotherapy D1 -- -- -- -- -- -- -- -- -- -- -- D12 - Capecitabine 825 mg/m2 , twice daily 1.2 control arm Standard concurrent chemoradiotherapy ( CRT ) - Radiotherapy , 50.4 Gy/28 fraction 6 week ↓↓↓↓↓ ↓↓↓↓↓ ↓↓↓↓↓ ↓↓↓↓↓ ↓↓↓↓↓ ↓↓↓ Radical surgery D1 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- D38 - Bolus 5-FU , 400 mg/ m2 leucovorin , 20 mg/ m2 week 1 5 - Capecitabine , 825 mg/ m2 , bid</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>1. histologically confirm adenocarcinoma ; 2. distal margin tumor locate &lt; 10 cm anal verge ; 3. cT34N02 classification determine magnetic resonance imaging ( MRI ) and/or endorectal ultrasonography ( EUS ) ; 4. evidence distant metastasis ; 5 . Karnofsky performance score 70 ; 6. adequate bone marrow , liver , renal function ( leucocytes &gt; 4000/mm3 , hemoglobin &gt; 10 g/dL , platelet &gt; 100,000/mm3 ; serum bilirubin &lt; 1.5 mg/dL , serum transaminase &lt; 2.5 time upper normal limit ; serum creatinine &lt; 1.5 mg/dL ) . 1 . Metastatic disease 2 . No complete resection tumor ( R2 )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>tumor response</keyword>
	<keyword>toxicity</keyword>
	<keyword>recurrence</keyword>
	<keyword>chemoradiotherpy</keyword>
	<keyword>rectum</keyword>
</DOC>